(CIDRAP News) – The US National Institutes of Health (NIH) has endorsed the recommendations of its biosecurity advisory committee to publish the full versions of two studies describing lab-modified, mammalian-transmissible H5N1 flu viruses, NIH officials announced today.
(CIDRAP News) In an effort to modernize vaccine production while preparing for an influenza pandemic, the US government today awarded five contracts totaling more than $1 billion to develop cell-based technologies for making flu vaccines.
(CIDRAP News) Public health experts will meet in Geneva next week to continue developing the World Health Organization's (WHO's) draft plan for quick action to head off a potential influenza pandemic.
The WHO announced the meeting as a Hong Kong official reported another possible human case of H5N1 avian flu in China, involving a 32-year-old man who died yesterday.
Jan 20, 2005 (CIDRAP News) Researchers who analyzed numerous clinical trials concluded that the two newest antiviral drugs for influenza, oseltamivir (Tamiflu) and zanamivir (Relenza), should not routinely be used against seasonal flua recommendation flatly rejected by the manufacturer of oseltamivir.